Jump to main content
Jump to site search

Issue 26, 2018
Previous Article Next Article

Valdecoxib vs. borazavaldecoxib: isoxazole BN/CC isosterism as a case study in designing and stabilizing boron heterocycles

Author affiliations

Abstract

A comprehensive study on the preparation, hydrolytic stability, and the structural and spectrophotometric properties of 1,2,4,5-oxadiazaboroles is presented by way of a comparison between the NSAID drug valdecoxib (1) and its unprecedented B–N isostere, borazavaldecoxib (2). Knowledge gained from this study was employed in the design of oxadiazaborate salts, a novel class of tetrahedral boron heterocycles displaying good stability in aqueous conditions with promising antifungal and antibacterial properties.

Graphical abstract: Valdecoxib vs. borazavaldecoxib: isoxazole BN/CC isosterism as a case study in designing and stabilizing boron heterocycles

Back to tab navigation

Supplementary files

Publication details

The article was received on 28 Apr 2018, accepted on 08 Jun 2018 and first published on 08 Jun 2018


Article type: Paper
DOI: 10.1039/C8OB00998H
Citation: Org. Biomol. Chem., 2018,16, 4849-4856
  •   Request permissions

    Valdecoxib vs. borazavaldecoxib: isoxazole BN/CC isosterism as a case study in designing and stabilizing boron heterocycles

    M. Boghi and D. G. Hall, Org. Biomol. Chem., 2018, 16, 4849
    DOI: 10.1039/C8OB00998H

Search articles by author

Spotlight

Advertisements